6-K
Smith & Nephew PLC (SNN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
June 06, 2025
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ✓ Form 40-F __
SMITH & NEPHEW PLC
6 June 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).
On 6 June 2025, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.
| Reason for the notification | ||||
|---|---|---|---|---|
| Initial<br>notification/Amendment | Initial<br>notification | |||
| Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| Name | Smith<br>& Nephew plc | |||
| LEI | 213800ZTMDN8S67S1H61 | |||
| Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transactions have been<br>conducted | ||||
| Description<br>of the financial instrument, type of instrument | Smith<br>& Nephew plc SPON ADR American Depositary Shares<br>(ADS) | |||
| Identification<br>code | ISIN:<br>US83175M2052 | |||
| Nature<br>of the transaction | Director and PDMRs are participants of the Company's Employee Stock<br>Purchase Plan, which purchased American Depository Shares through<br>the Company's Dividend Re-Investment Plan following the 2024 final<br>dividend payment on 28 May 2025. | |||
| Date of<br>Transaction | 2025-06-04 | |||
| Place<br>of Transaction | New<br>York Stock Exchange | |||
| Name | Director / PDMR | Price ($) | Volume | Aggregated information |
| --- | --- | --- | --- | --- |
| Craig<br>Gaffin<br><br><br>(President,<br>Global Orthopaedics) | PDMR | 29.3442 | 33.73275 | N/A<br>Single Transaction |
| Mizanu<br>Kebede<br><br><br>(Chief<br>Quality & Regulatory Affairs Officer) | PDMR | 29.3442 | 19.37144 | N/A<br>Single Transaction |
| Deepak<br>Nath<br><br><br>(Chief<br>Executive Officer) | Director | 29.3442 | 35.79737 | N/A<br>Single Transaction |
| Paul<br>Connolly<br><br><br>(President,<br>Global Operations) | PDMR | 29.3442 | 35.64110 | N/A<br>Single Transaction |
| Scott<br>Schaffner<br><br><br>(President,<br>Sports Medicine) | PDMR | 29.3442 | 46.62612 | N/A<br>Single Transaction |
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Smith & Nephew plc | ||
|---|---|---|
| (Registrant) | ||
| Date:<br>June 06, 2025 | By: | /s/<br>Helen Barraclough |
| Helen<br>Barraclough | ||
| Company<br>Secretary |